August 18, 2021
Teva Pharmaceuticals asked a Massachusetts federal court on Wednesday to sanction Eli Lilly and Co. in their battle over patents tied to a migraine biologic, claiming that the rival failed to obey a court order requiring it to use specific search terms in its collection of electronically stored information.
September 28, 2018
Hours after a Massachusetts federal judge said Teva Pharmaceuticals couldn't sue Eli Lilly & Co. for infringing patents tied to a migraine biologic because Lilly's version lacked U.S. Food and Drug Administration approval, the agency cleared the drug and Teva sued again.